>_ QFI Terminal
Terminal › Stocks › MOVE

Movano Inc. (MOVE) Stock

Healthcare · Medical - Devices · US
$14.62 +35.87%
Last updated Nov 12, 2026 09:32 UTC

MOVE Key Statistics

Market Cap$11.09M
P/E (TTM)-0.67
P/S (TTM)25.62
P/B (TTM)-3,565.85
Revenue (TTM)$433,000.00
EPS (TTM)$-21.79
Dividend Yield—
ROE (TTM)9,999.99%
Net Margin-6,207.16%
Gross Margin-424.94%
52W High$26.72
52W Low$7.52
Analyst ViewBuy
Price Target—
Employees32
Volume7,065,334

About Movano Inc.

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.

CEO: Jay Crystal. Company website

MOVE — Frequently Asked Questions

What is the MOVE stock price today?

Movano Inc. (MOVE) trades at $14.62, up 35.87% on the day, as of Nov 12, 2026 09:32 UTC.

What is Movano Inc.'s market cap?

Movano Inc. has a market capitalisation of $11.09M, calculated from the live MOVE share price and shares outstanding.

What is the P/E ratio of MOVE?

MOVE has no meaningful price-to-earnings ratio: Movano Inc. lost $21.79 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Movano Inc. make?

Movano Inc. generated revenue of $433,000.00 over the trailing twelve months, which puts the stock at 25.62 times sales.

What is the 52-week range for MOVE?

MOVE has traded between $7.52 and $26.72 over the past 52 weeks, and the last price is 45.3% below that high.

Is Movano Inc. profitable?

No. Movano Inc. is loss-making, with a net margin of -6,207.16% over the trailing twelve months.

What is the analyst price target for MOVE?

Wall Street analysts rate MOVE Buy.

What sector is Movano Inc. in?

Movano Inc. is classified under the Healthcare sector and the Medical - Devices industry, and is domiciled in US .

Who is the CEO of Movano Inc.?

Jay Crystal is the chief executive of Movano Inc., which employs 32 people.

Where can I track MOVE in real time?

QFI Terminal shows MOVE with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See MOVE live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open MOVE in Terminal See plans

Medical - Devices stocks

ABT Abbott Laboratories MDT Medtronic Plc SYK Stryker Corporation GEHC GE HealthCare Technologies Inc. BSX Boston Scientific Corporation ZBH Zimmer Biomet Holdings, Inc. EW Edwards Lifesciences Corporation SNN Smith & Nephew plc DXCM DexCom, Inc. ALGN Align Technology, Inc. BRKR Bruker Corporation PODD Insulet Corp. GMED Globus Medical, Inc. BIO Bio-Rad Laboratories, Inc. ITGR Integer Holdings Corporation IART Integra LifeSciences Holdings Corporation PEN Penumbra, Inc. HAE Haemonetics Corporation TNDM Tandem Diabetes Care, Inc. NEOG Neogen Corporation TMDX TransMedics Group, Inc. AVNS Avanos Medical, Inc. GKOS Glaukos Corporation INMD InMode Ltd.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc.

MOVE insiders on other boards

WULF TeraWulf Inc. Fleury Patrick